Larimar Therapeutics (LRMR) Insider Trading & Ownership $2.31 +0.03 (+1.32%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$2.27 -0.04 (-1.73%) As of 03/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Larimar Therapeutics (NASDAQ:LRMR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$39.65 MNumber OfInsiders Selling(Last 3 Years)0 Get LRMR Insider Trade Alerts Want to know when executives and insiders are buying or selling Larimar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LRMR Insider Buying and Selling by Quarter Remove Ads Larimar Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/16/2024James E FlynnDirectorBuy4,290,617$8.74$37,499,992.58 2/14/2024Frank E ThomasDirectorBuy2,000$11.00$22,000.00 5/17/2023Joseph TruittDirectorBuy2,750$3.73$10,257.50 5/17/2023Michael CelanoCFOBuy5,000$3.73$18,650.00 9/16/2022Michael CelanoCFOBuy31,746$3.15$99,999.90 9/16/2022Thomas Edward HamiltonDirectorBuy317,460$3.15$999,999.00 9/16/2022Thomas Edward HamiltonDirectorBuy317,460$3.15$999,999.00 (Data available from 1/1/2013 forward) LRMR Insider Trading Activity - Frequently Asked Questions Who is on Larimar Therapeutics's Insider Roster? The list of insiders at Larimar Therapeutics includes Frank E Thomas, James E Flynn, Joseph Truitt, Michael Celano, and Thomas Edward Hamilton. Learn more on insiders at LRMR. What percentage of Larimar Therapeutics stock is owned by insiders? 3.50% of Larimar Therapeutics stock is owned by insiders. Learn more on LRMR's insider holdings. Which Larimar Therapeutics insiders have been buying company stock? The following insiders have purchased LRMR shares in the last 24 months: Frank E Thomas ($22,000.00), James E Flynn ($37,499,992.58), Joseph Truitt ($10,257.50), and Michael Celano ($18,650.00). How much insider buying is happening at Larimar Therapeutics? Insiders have purchased a total of 4,300,367 LRMR shares in the last 24 months for a total of $37,550,900.08 bought. Larimar Therapeutics Key ExecutivesDr. Carole S. Ben-Maimon M.D. (Age 65)CEO, President & Director Compensation: $865kMr. Michael Celano CPA (Age 65)Secretary & CFO Compensation: $577.58kDr. Gopi Shankar M.B.A. (Age 53)Ph.D., Chief Development Officer Compensation: $593.02kMr. John BermanVice President of Finance & AdministrationMs. Jennifer Spokes JohanssonVice President of Legal & ComplianceDr. Russell G. Clayton Sr. (Age 63)D.O, D.O., Chief Medical Officer Mr. Francis Michael Conway CPAVP & Controller More Insider Trading Tools from MarketBeat Related Companies DNTH Insider Transactions LENZ Insider Transactions CRMD Insider Transactions ORGO Insider Transactions SANA Insider Transactions CDXC Insider Transactions KALV Insider Transactions MGTX Insider Transactions ARVN Insider Transactions RLAY Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:LRMR) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Larimar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
